[HTML][HTML] Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients
H Kawasuji, Y Takegoshi, M Kaneda, A Ueno… - PloS one, 2020 - journals.plos.org
Objective To investigate the relationship between viral load and secondary transmission in
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
novel coronavirus disease 2019 (COVID-19). Methods Epidemiological and clinical data …
SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19
…, M Kaneda, Y Murai, K Kimoto, A Ueno… - Journal of Medical …, 2022 - Wiley Online Library
This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
association with the clinical severity of COVID‐19. This retrospective cohort study performed at …
[HTML][HTML] Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
…, M Saijo, K Sano, T Suzuki, H Kawasuji, A Ueno… - Virology journal, 2021 - Springer
Background SARS-CoV-2 is a novel coronavirus that emerged in 2019 and is now
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
classified in the genus Coronavirus with closely related SARS-CoV. SARS-CoV-2 is highly …
Correlation of the commercial anti-SARS-CoV-2 receptor binding domain antibody test with the chemiluminescent reduction neutralizing test and possible detection of …
…, R Yasukochi, M Kaneda, Y Murai, A Ueno… - Microbiology …, 2021 - Am Soc Microbiol
Serological tests are beneficial for recognizing the immune response against severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, …
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity, …
[HTML][HTML] Circulating type I interferon levels in the early phase of COVID-19 are associated with the development of respiratory failure
…, H Kawasuji, Y Murai, M Kaneda, A Ueno… - Frontiers in …, 2022 - frontiersin.org
Background The role of type I interferons (IFNs) in the early phase of COVID-19 remains
unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID-19 …
unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID-19 …
[HTML][HTML] Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients
H Kawasuji, Y Tsuji, C Ogami, K Kimoto, A Ueno… - BMC Pharmacology and …, 2021 - Springer
Background Linezolid is administered as a fixed dose to all patients despite evidence of
overexposure and thrombocytopenia in renal impairment. The aims of this study were to …
overexposure and thrombocytopenia in renal impairment. The aims of this study were to …
Neutralizing antibody response of the wild-type/omicron BA. 1 bivalent vaccine as the second booster dose against omicron BA. 2 and BA. 5
…, M Kaneda, Y Murai, K Kimoto, A Ueno… - Microbiology …, 2023 - Am Soc Microbiol
In addition to the original monovalent vaccines available for SARS-CoV-2, bivalent vaccines
covering wild-type (WT) and Omicron BA.1 are also available. However, there is a lack of …
covering wild-type (WT) and Omicron BA.1 are also available. However, there is a lack of …
Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity
…, H Tani, Y Saga, M Kaneda, Y Murai, A Ueno… - Microbiology …, 2021 - Am Soc Microbiol
Vaccines against severe acute respiratory syndrome coronavirus-2 have been introduced.
To investigate the relationship between vaccine-induced humoral immunity and patient age, …
To investigate the relationship between vaccine-induced humoral immunity and patient age, …
[HTML][HTML] Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19
…, Y Takegoshi, M Kaneda, Y Murai, K Kimoto, A Ueno… - Scientific Reports, 2021 - nature.com
Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …
dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with …
Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population
A Ueno, H Kawasuji, Y Miyajima, Y Fukui… - Journal of Infection and …, 2021 - Elsevier
Introduction The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) …
RNA by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) …
